Therefore, elevated GRK2 in breast cancer patients may facilitate a pro-survival cellular state (low p53 and high AKT levels), whereas GRK2 downmodulation promotes a pro-apoptotic state (high p53 and low AKT levels). The gene discussed is TP53; the disease is breast cancer.